Φορτώνει......
SUN-412 A Unique Case of Isolated ACTH Deficiency Caused by Pembrolizumab
Background: The anti-programmed-death-receptor-1 (PD-1) antibody, pembrolizumab, is one of the key immunomodulators for different types of refractory cancers. It is known to cause a variety of endocrinopathies including hypothyroidism, hyperthyroidism, diabetes mellitus, hypophysitis and primary adr...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Endocr Soc |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Endocrine Society
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553144/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-412 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|